1070nm Trial PUblished by Durham University

Our colleagues at Durham published a pilot trial of the transcranial 1070nm photobiomodulation device this week. It has garnered a good deal of media attention which is certainly welcome and hopefully will encourage more people to take up the use of these devices. 

Quietmind Fdn. is now making them available to people in the context of single subject trials. The cost of the Cognitoite units are $7650 while the newer designed units developed by the team at Cognitolite and Neuronic Medical Devices LLC is $3995. Details at [email protected]  

​https://www.medscape.com/viewarticle/961326